Long-term follow-up after surgical treatment of infective endocarditis in children with congenital heart diseases

  • L. Prokopovуch National M. M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine (Kyiv)
  • O. Golovenko National M. M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine (Kyiv)
  • M. Rudenko National M. M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine (Kyiv)
  • S. Spysarenko National M. M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine (Kyiv)
  • T. Malysheva National M. M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine (Kyiv)
  • Y. Truba National M. M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine (Kyiv)
  • V. Lazoryshynetz National M. M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine (Kyiv)
Keywords: infective endocarditis, congenital heart diseases, surgical treatment follow-up examination

Abstract

The current work presents the experience of surgical treatment of infective endocarditis (IE) in children with congeni-tal heart diseases (CHD). During the period from Jan 2010 to Dec 2017 in Amosov National Institute of Cardiovascular Surgery, 32 children with IE and CHD were operated. The mean age of patients at operation was 11,6±5,7 years. Hospital mortality was 6,2% (2 patients). A total of 28 (93.3%) from 30 children who were discharged from the hospital were examined. The follow-up time was from five months to 10.1 years (5.9±2.5 years). The age of patients at the time of the examination varied from 2.1 to 24.3 years (17.1±7.8 years). There were two (7,1%) late deaths. The cumulative survival rate of patients at one year after the op-eration was 100%, 5 years – 96.2%, 10 years – 90.2%. In two (7.1%) patients, signs of IE were re-discovered. The proportion of patients without reoperations in the long-term follow-up at one year after surgery was 92.6%, 84.2% – at 5 years, 77.2% – at 10 years.

References

1. Characteristics of children hospitalized with infective endocarditis / Day M. D., Gauvreau K., Shulman S. et al. // Circulation. – 2009. – Vol. 119. – Р. 865–70.

2. The changing epidemiology of pediatric endocarditis at a children’s hospital over seven decades / Rosenthal L. B., Feja K. N., Levasseur S. M. et al. // Pediatr Cardiol. – 2010. – Vol. 31. – Р. 813–20.

3. Infective endocarditis in children: native valve preservation isnfrequently possible despite advanced clinical disease / E. J. Hickey, G. Jung, C. Manlhiot et al. // Eur J Cardiothorac Surg. – 2009. – Vol. 35. – Р. 130–135.

4. Early predictors of in hospital death in infective endocarditis / Chu V. H., Cabell C. H., Benjamin D. K. Jr. et al. // Circulation. – 2004. – Vol. 109, № 14. – Р. 1745–9.

5. 2017 AHA\ACC Focused Update of the AHA\ACC Guideline for the Management of patiens With Valvular Heart Disease: A Report of the American College of Cardiology / Nishimura R. A., Otto C. M., Bonow R. O. et al. // American Heart Assotiation Task Force on Clinical Practice Guidelines. Circulation 2017.

6. Infective Endocarditis in Children with Congenital Heart Disease. Cumulative incidence and predictors / Dinela Rushani, Jay S. Kaufman, Raluca lonescu-Ittu et al. // Circulation. – 2013. – Vol.128. – P. 1214–1419. Originally published September 23, 2013.

7. Incidence, predictors and mortality of Infective Endocarditis in adults with congenital heart disease without prosthetic valves / Darren Mylotte, MD, Dinela Rushani, MSc, Judith Therrien, MD, et al. // The American Journal of Cardiology. – December 15, 2017. – Vol. 120, Issue 12. – P. 2278–2283.

8. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America / Baddour L. M., Wilson W. R., Bayer A. S. et al. // Circulation. – 2005. – Vol. 111. – P. e394–434.

9. Analysis of the impact of early surgery on in-hospital mortality of native valve endocarditis: use of propensity score and instrumental variable methods to adjust for treatment-selection bias / T. Lalani, C. H. Cabell, D. K. Benjamin et al. // Circulation. – 2010. – Vol. 121. – P. 1005–1013.

10. Early surgical therapy of infective endocarditis in children: A 15-year experience / Pirouz Shamszad, MD., Muhammad S., Khan, MD // The Journal of Thoracic and Cardiovascular Surgery. – 2013, September. – Vol. 146, Issue 3. – P. 506–511.

11. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service / Durack D. T., Lukes A. S., Bright D.K. // Am J Med. – 1994. – Vol. 96. – P. 200–209.

12. Hoen B, Duval X. Clinical practice. Infective endocarditis // N Engl J Med. – 2013, Apr 11. – Vol. 368 (15). – P. 1425–33.

13. Infective endocarditis in the pediatric patient: a 60-year single-institution review / Johnson J. A., Boyce T. G., Cetta F. et al. // Mayo Clin Proc. – 2012, Jul. – Vol. 87 (7). – P. 629–35.
Published
2018-03-12
How to Cite
1.
ProkopovуchL, Golovenko O, Rudenko M, Spysarenko S, Malysheva T, Truba Y, Lazoryshynetz V. Long-term follow-up after surgical treatment of infective endocarditis in children with congenital heart diseases. ujcvs [Internet]. 2018Mar.12 [cited 2024Dec.22];(1 (30):53-9. Available from: https://cvs.org.ua/index.php/ujcvs/article/view/99
Section
CONGENITAL HEART DEFECTS

Most read articles by the same author(s)